malignant solid neoplasm
Showing 51 - 75 of 168
Nutritional Interventions Among Cancer Patients
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Interview
- Survey Administration
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Dec 13, 2022
Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma
Recruiting
- Clinical Stage I Cutaneous Melanoma AJCC v8
- +33 more
- Informational Intervention
- +4 more
-
Los Angeles, California
- +4 more
Dec 14, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in
Active, not recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- Best Practice
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Malignant Solid Tumor Trial (Biospecimen Collection, Cryocompression Therapy, Pneumatic Compression Therapy)
Not yet recruiting
- Malignant Solid Neoplasm
- Biospecimen Collection
- +4 more
- (no location specified)
Nov 30, 2022
Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,
Recruiting
- Cervical Adenocarcinoma
- +47 more
- Bevacizumab
- +3 more
-
Phoenix, Arizona
- +3 more
Dec 5, 2022
Identifying Malnutrition in Older Cancer Participants
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Comprehensive Geriatric Assessment
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Adult Liver Carcinoma, Gastric Carcinoma, Malignant Solid Tumor Trial in Columbus (other, behavioral, procedure)
Recruiting
- Adult Liver Carcinoma
- +3 more
- Best Practice
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 23, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Memphis, Seattle (Behavioral Intervention, Survey
Enrolling by invitation
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Behavioral Intervention
- Survey Administration
-
Memphis, Tennessee
- +1 more
Nov 18, 2022
l Empathy of Healthcare Practitioners From Department of
Active, not recruiting
- COVID-19 Infection
- +2 more
- Best Practice
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 8, 2022
Malignant Solid Tumor, Ovarian Low Grade Serous Adenocarcinoma, Pancreatic Carcinoma Trial (Binimetinib, Biopsy, Biospecimen
Not yet recruiting
- Malignant Solid Neoplasm
- +4 more
- Binimetinib
- +6 more
- (no location specified)
Nov 8, 2022
Malignant Solid Tumor Trial in United States (drug, other, procedure)
Active, not recruiting
- Malignant Solid Neoplasm
- Ferumoxytol
- +4 more
-
Baltimore, Maryland
- +5 more
Nov 8, 2022
National Cancer Institute "Cancer Moonshot Biobank"
Recruiting
- Acute Myeloid Leukemia
- +33 more
- Biospecimen Collection
- Medical Chart Review
-
Kingman, Arizona
- +99 more
Nov 3, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Sleep Disorder Trial in Houston (other, drug, procedure)
Active, not recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- Counseling
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Oct 31, 2022
COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients
Recruiting
- COVID-19 Infection
- +2 more
- Quality-of-Life Assessment
- Survey Administration
-
Houston, TexasM D Anderson Cancer Center
Oct 20, 2022
Project: Every Child for Younger Patients With Cancer
Recruiting
- Carcinoma In Situ
- +10 more
- Cytology Specimen Collection Procedure
- Medical Chart Review
-
Birmingham, Alabama
- +240 more
Oct 19, 2022
Liposarcoma, Malignant Abdominal Tumor, Malignant Retroperitoneal Tumor Trial in Portland (drug, radiation, other, procedure)
Recruiting
- Liposarcoma
- +5 more
- Eribulin Mesylate
- +5 more
-
Portland, OregonOHSU Knight Cancer Institute
Oct 17, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Houston (Behavioral Intervention, Interview,
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Behavioral Intervention
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 14, 2022
Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma
Recruiting
- Clinical Stage 0 Cutaneous Melanoma AJCC v8
- +43 more
- Best Practice
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +41 more
- Ipilimumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 11, 2022
Chemo-Induced Peripheral Neuropathy, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Houston (drug,
Recruiting
- Chemotherapy-Induced Peripheral Neuropathy
- +2 more
- Duloxetine
- +3 more
-
Houston, Texas
- +1 more
Oct 6, 2022
Preliminary Testing of MD Anderson Symptom Inventory
Active, not recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Interview
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 27, 2022
COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors
Recruiting
- COVID-19 Infection
- Malignant Solid Neoplasm
- Quality-of-Life Assessment
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Solid Tumor Trial in Orland Park, Seattle (Nozin, Best Practice)
Suspended
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- Nozin
- Best Practice
-
Orland Park, Illinois
- +1 more
Sep 20, 2022
Interviews, Screening, Healthcare Workers Trial in Houston (First Interview, Second Interview, 8-week multicomponent
Recruiting
- Anxiety Disorder
- +2 more
- Behavioral Intervention
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 7, 2022
Prediction in Solid Tumors
Recruiting
- Malignant Solid Neoplasm
- Biospecimen Collection
- Questionnaire Administration
-
Ames, Iowa
- +5 more
Sep 7, 2022